![Patrick Machado](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Machado
Presidente presso
ADVERUM BIOTECHNOLOGIES, INC.
Patrimonio netto: 2 M $ in data 30/06/2026
Profilo
Mr. Clarence P.
Machado is an Independent Director at Alumis, Inc., an Independent Director at Xenon Pharmaceuticals, Inc., an Independent Director at Arcus Biosciences, Inc., a Chairman at Adverum Biotechnologies, Inc. and a Chairman at Prota Therapeutics Pty Ltd. He is on the Board of Directors at Alumis, Inc., Xenon Pharmaceuticals, Inc., Arcus Biosciences, Inc., Auransa, Inc. and Avenzo Therapeutics, Inc. Mr. Machado was previously employed as an Independent Director by ACELYRIN, Inc., an Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Turnstone Biologics Corp., an Independent Director by Endocyte, Inc., an Independent Director by Roivant Sciences Ltd., an Independent Director by Inotek Pharmaceuticals Corp., an Independent Director by SCYNEXIS, Inc., a Chairman by Armaron Bio Ltd., an Independent Director by Chimerix, Inc., a Chief Financial Officer, Director & Senior VP by Medivation Neurology LLC, a Consultant by Nor'easter Corp., a Chief Financial Officer & Senior Vice President by Pro-Duct Health, Inc., a Chief Legal Counsel by Chiron Corp., an Independent Director by Montes Archimedes Acquisition Corp., a Principal by Morrison & Foerster LLP, a Chief Financial Officer by Orion Acquisition Corp.
II, and a Member-Supervisory Board by Therachon Holding GmbH.
He also served on the board at Principia Biopharma, Inc., Therachon AG, Axovant Sciences, Inc., Axovant Gene Therapies Ltd., Medivation LLC (California), Medivation, Inc. /Old/ and Roivant Sciences, Inc. He received his undergraduate degree from Santa Clara University and a graduate degree from Harvard Law School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 44.300 ( 0,04% ) | 1 M $ | 30/06/2026 | |
ALUMIS INC. 0,01% | 30/06/2026 | 10.617 ( 0,01% ) | 298 762 $ | 30/06/2026 |
| 03/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Patrick Machado
| Società | Posizione | Inizio |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Presidente | 01/05/2019 |
| ARCUS BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 10/12/2019 |
| XENON PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 05/11/2020 |
| ALUMIS INC. | Direttore/Membro del Consiglio | 01/06/2024 |
ProTA Therapeutics Pty Ltd.
 ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Presidente | - |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Direttore/Membro del Consiglio | - |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Patrick Machado
| Società | Posizione | Fine |
|---|---|---|
| ACELYRIN, INC. | Direttore/Membro del Consiglio | 21/05/2025 |
| CHIMERIX, INC. | Direttore/Membro del Consiglio | 20/06/2024 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Patrick Machado
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
33
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 33 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Medivation, Inc. /Old/
 Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Armaron Bio Ltd.
 Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops cardioprotection and neuroprotection small molecules to reduce tissue damage for heart attacks | Electronic Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Health Technology |
ProTA Therapeutics Pty Ltd.
ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Therachon AG | |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
